Understanding GLP-1: The First Target GLP-1 became the first incretin targeted for pharmaceutical development, leading to medications like exenatide, liraglutide, and eventually semaglutide
Clinical trials have proven that semaglutide is effective in weight management when combined with a proper diet and exercise plan
Available from, as of September 5, 2018: Large IV doses of methylene blue may produce nausea, vomiting, abdominal pain, precordial pain, dizziness, headache, profuse sweating, dyspnea, hypertension, and mental confusion
This sounds basic because it is basic
Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG
Ask flight attendants about refrigeration options available on your flight